Lv3
384 积分 2024-01-31 加入
Structure-based design of Sec61 translocon targeting prodrugs minimize off-target toxicity
28天前
已完结
PCSK9 inhibitors: a patent review 2018-2023
1个月前
已完结
PCSK9 inhibitors: an updated patent review 2024–2025
1个月前
已完结
A patent review of NLRP3 inhibitors for inflammatory diseases (2023-present)
1个月前
已完结
Cystine C–S bond cleavage fuels cysteine production under disulfide reductase deficiency
1个月前
已完结
Selective epimerization of GlcNAc to GalNAc through steady-state tuning under kinetic network control
5个月前
已完结
PCMT1 generates the C-terminal cyclic imide degron on CRBN substrates
6个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
6个月前
已完结
Discovering covalent inhibitors of protein–protein interactions from trillions of sulfur(VI) fluoride exchange-modified oligonucleotides
7个月前
已完结
RNA-based therapeutic opportunities for the treatment of kidney diseases
8个月前
已完结
皖公网安备34019202002308
